T1	PROC 749 759	evaluación
#1	AnnotatorNotes T1	C1261322; Evaluation procedure; Health Care Activity
T2	CHEM 25 56	aceite de Copaifera officinalis
#2	AnnotatorNotes T2	C3256143; Copiba oil; Organic Chemical
T3	DISO 85 99	úlcera péptica
#3	AnnotatorNotes T3	C0030920; Peptic Ulcer; Disease or Syndrome
T4	CHEM 152 169	aceite de copaiba
#4	AnnotatorNotes T4	C3256143; Copiba oil; Organic Chemical
T5	CHEM 233 242	omeprazol
#5	AnnotatorNotes T5	C0028978; omeprazole; Organic Chemical · Pharmacologic Substance
T6	DISO 293 307	úlcera péptica
#6	AnnotatorNotes T6	C0030920; Peptic Ulcer; Disease or Syndrome
T7	PROC 318 411	Estudio experimental, clínico comparativo, de fase II, aleatorio, doble ciego, grupo paralelo
#7	AnnotatorNotes T7	C0678323; experimentation; Research Activity + C1579762; comparative study research; Research Activity + C0282460; Phase 2 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C2826345; Parallel Study; Research Activity
T8	PROC 956 980	consentimiento informado
#8	AnnotatorNotes T8	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T9	DISO 598 612	úlcera péptica
#9	AnnotatorNotes T9	C0030920; Peptic Ulcer; Disease or Syndrome
T10	PROC 615 629	Intervenciones
#10	AnnotatorNotes T10	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T11	PROC 634 645	diagnóstico
#11	AnnotatorNotes T11	C0011900; Diagnosis; Diagnostic Procedure
T12	PROC 660 678	exploración física
#12	AnnotatorNotes T12	C0031809; Physical Examination; Health Care Activity
T13	PROC 710 720	endoscopia
#13	AnnotatorNotes T13	C0014245; Endoscopy (procedure); Diagnostic Procedure
T14	CHEM 785 802	aceite de copaiba
#14	AnnotatorNotes T14	C3256143; Copiba oil; Organic Chemical
T15	PROC 848 862	ensayo clínico
#15	AnnotatorNotes T15	C0008976; Clinical Trials; Research Activity
T16	PROC 904 914	ingresaron
#16	AnnotatorNotes T16	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T17	PROC 1066 1093	distribuidos aleatoriamente
#17	AnnotatorNotes T17	C0034656; Randomization; Research Activity
T18	CHEM 1203 1220	aceite de copaiba
#18	AnnotatorNotes T18	C3256143; Copiba oil; Organic Chemical
T19	CHEM 1290 1299	omeprazol
#19	AnnotatorNotes T19	C0028978; omeprazole; Organic Chemical · Pharmacologic Substance
T20	PROC 1311 1323	tratamientos
#20	AnnotatorNotes T20	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T21	PROC 1331 1354	administrados en ayunas
T22	DISO 1785 1799	úlcera péptica
#21	AnnotatorNotes T22	C0030920; Peptic Ulcer; Disease or Syndrome
T23	CHEM 1804 1821	aceite de copaiba
#22	AnnotatorNotes T23	C3256143; Copiba oil; Organic Chemical
T24	CHEM 1867 1876	omeprazol
#23	AnnotatorNotes T24	C0028978; omeprazole; Organic Chemical · Pharmacologic Substance
T25	DISO 1882 1898	efectos adversos
#24	AnnotatorNotes T25	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T26	DISO 1931 1938	náuseas
#25	AnnotatorNotes T26	C0027497; Nausea; Sign or Symptom
T27	DISO 1946 1959	epigastralgia
#26	AnnotatorNotes T27	C0232493; Epigastric pain; Sign or Symptom
T28	DISO 1994 2008	úlcera péptica
#27	AnnotatorNotes T28	C0030920; Peptic Ulcer; Disease or Syndrome
T29	PROC 2015 2026	tratamiento
#28	AnnotatorNotes T29	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T30	CHEM 2055 2072	aceite de copaiba
#29	AnnotatorNotes T30	C3256143; Copiba oil; Organic Chemical
T31	DISO 2103 2109	úlcera
#30	AnnotatorNotes T31	C0041582; Ulcer; Pathologic Function
T32	DISO 2128 2144	efectos adversos
#31	AnnotatorNotes T32	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T33	PROC 112 134	Determinar la eficacia
#32	AnnotatorNotes T33	C1707887; Efficacy Study; Research Activity
T34	PROC 267 278	diagnóstico
#33	AnnotatorNotes T34	C0011900; Diagnosis; Diagnostic Procedure
T35	PROC 572 583	diagnóstico
#34	AnnotatorNotes T35	C0011900; Diagnosis; Diagnostic Procedure
T36	LIVB 71 80	pacientes
#35	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group
T37	LIVB 196 217	Copaifera officinalis
#36	AnnotatorNotes T37	C1942510; Copaifera officinalis; Plant
T38	Dose 243 248	20 mg
T39	LIVB 253 262	pacientes
#37	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group
T43	LIVB 558 567	Pacientes
#38	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T44	Form 817 825	cápsulas
#39	AnnotatorNotes T44	C4722245; Capsule Dose Form Category; Functional Concept
T45	Dose 829 834	80 mg
T46	Dose 837 843	120 mg
T47	LIVB 874 883	pacientes
#40	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	LIVB 1049 1058	pacientes
#41	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	Form 1191 1199	cápsulas
#42	AnnotatorNotes T49	C4722245; Capsule Dose Form Category; Functional Concept
T50	Dose 1234 1245	80 y 120 mg
T51	Dose 1300 1305	20 mg
T52	Frequency 1356 1377	una vez por la mañana
T53	Duration 1379 1389	30 minutos
T54	PHYS 1402 1409	ingesta
#43	AnnotatorNotes T54	C0232478; Ingestion; Biologic Function
T55	Neg_cue 1878 1881	sin
T56	LIVB 1980 1989	pacientes
#44	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	Form 2034 2042	cápsulas
#45	AnnotatorNotes T57	C4722245; Capsule Dose Form Category; Functional Concept
T59	Neg_cue 2124 2127	sin
T65	PROC 1564 1588	consentimiento informado
#46	AnnotatorNotes T65	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T66	PHYS 1715 1728	cicatrización
#47	AnnotatorNotes T66	C0043240; Wound Healing; Organism Function
T67	PHYS 1765 1778	cicatrización
#48	AnnotatorNotes T67	C0043240; Wound Healing; Organism Function
T68	LIVB 1814 1821	copaiba
#49	AnnotatorNotes T68	C1942510; Copaifera officinalis; Plant
T69	LIVB 2065 2072	copaiba
#50	AnnotatorNotes T69	C1942510; Copaifera officinalis; Plant
T70	PHYS 2083 2096	cicatrización
#51	AnnotatorNotes T70	C0043240; Wound Healing; Organism Function
T63	LIVB 35 56	Copaifera officinalis
#52	AnnotatorNotes T63	C1942510; Copaifera officinalis; Plant
T64	LIVB 58 65	copaiba
#53	AnnotatorNotes T64	C1942510; Copaifera officinalis; Plant
T40	Date 760 780	pre y postratamiento
T41	LIVB 795 802	copaiba
#54	AnnotatorNotes T41	C1942510; Copaifera officinalis; Plant
T42	LIVB 1213 1220	copaiba
#55	AnnotatorNotes T42	C1942510; Copaifera officinalis; Plant
T58	LIVB 543 556	Participantes
#56	AnnotatorNotes T58	C4554048; Study Participant; Population Group
A1	Assertion T32 Negated
A2	Assertion T25 Negated
R1	Experiences Arg1:T36 Arg2:T3	
R2	Experiences Arg1:T36 Arg2:T2	
T60	Observation 1 20	Efecto cicatrizante
R3	Causes Arg1:T2 Arg2:T60	
R4	Experiences Arg1:T36 Arg2:T60	
R5	Overlap Arg1:T60 Arg2:T3	
R6	Has_Dose_or_Strength Arg1:T5 Arg2:T38	
R7	Experiences Arg1:T39 Arg2:T4	
T61	LIVB 162 169	copaiba
#57	AnnotatorNotes T61	C1942510; Copaifera officinalis; Plant
R8	Experiences Arg1:T39 Arg2:T5	
T62	Quantifier_or_Qualifier 279 289	definitivo
R9	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T62	
R11	Experiences Arg1:T39 Arg2:T6	
R15	Experiences Arg1:T43 Arg2:T9	
R17	Experiences Arg1:T58 Arg2:T9	
T71	Quantifier_or_Qualifier 584 594	definitivo
R18	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T71	
R19	Overlap Arg1:T1 Arg2:T40	
R20	Overlap Arg1:T13 Arg2:T40	
R21	Overlap Arg1:T12 Arg2:T40	
R23	Overlap Arg1:T12 Arg2:T1	
R24	Has_Drug_Form Arg1:T14 Arg2:T44	
R25	Has_Dose_or_Strength Arg1:T14 Arg2:T45	
R26	Has_Dose_or_Strength Arg1:T14 Arg2:T46	
R27	Before Arg1:T12 Arg2:T11	
R28	Before Arg1:T13 Arg2:T11	
T72	Quantifier_or_Qualifier 888 903	voluntariamente
R29	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T72	
R30	Before Arg1:T8 Arg2:T16	
R32	Before Arg1:T17 Arg2:T18	
R33	Experiences Arg1:T48 Arg2:T18	
R34	Has_Drug_Form Arg1:T18 Arg2:T49	
R35	Has_Dose_or_Strength Arg1:T18 Arg2:T50	
R36	Before Arg1:T17 Arg2:T19	
R37	Has_Dose_or_Strength Arg1:T19 Arg2:T51	
R38	Experiences Arg1:T48 Arg2:T19	
T73	Observation 1345 1354	en ayunas
#58	AnnotatorNotes T73	C0015663; Fasting; Finding
R39	Overlap Arg1:T20 Arg2:T73	
R40	Has_Frequency Arg1:T20 Arg2:T52	
R41	Overlap Arg1:T20 Arg2:T53	
R42	Before Arg1:T20 Arg2:T54	
T74	Food 1421 1429	alimento
#59	AnnotatorNotes T74	C0016452; Food; Food
R43	Used_for Arg1:T74 Arg2:T54	
T75	CONC 1467 1489	técnicas multivariadas
#60	AnnotatorNotes T75	C0026777; Multivariate Analysis; Quantitative Concept
T76	CONC 1701 1728	Porcentaje de cicatrización
R44	Before Arg1:T22 Arg2:T67	
R45	Causes Arg1:T23 Arg2:T67	
R46	Causes Arg1:T24 Arg2:T67	
R47	Negation Arg1:T55 Arg2:T25	
R48	Negation Arg1:T59 Arg2:T32	
T77	Quantifier_or_Qualifier 2145 2159	significativos
A3	Assertion T77 Negated
#61	AnnotatorNotes T77	C0750502; Significant; Idea or Concept
R49	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T77	
T78	Quantifier_or_Qualifier 1899 1913	significativos
A4	Assertion T78 Negated
#62	AnnotatorNotes T78	C0750502; Significant; Idea or Concept
R50	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T78	
R51	Before Arg1:T23 Arg2:T25	
R52	Causes Arg1:T23 Arg2:T26	
R53	Causes Arg1:T23 Arg2:T27	
R54	Experiences Arg1:T56 Arg2:T28	
R55	Experiences Arg1:T56 Arg2:T29	
R56	Has_Drug_Form Arg1:T30 Arg2:T57	
R57	Used_for Arg1:T30 Arg2:T29	
R58	Causes Arg1:T30 Arg2:T70	
R59	Before Arg1:T31 Arg2:T70	
R60	Experiences Arg1:T56 Arg2:T31	
R61	Experiences Arg1:T56 Arg2:T70	
R62	Experiences Arg1:T56 Arg2:T32	
R63	Before Arg1:T30 Arg2:T32	
#63	AnnotatorNotes T62	C0443196; Definitive; Temporal Concept
#64	AnnotatorNotes T71	C0443196; Definitive; Temporal Concept
R10	Before Arg1:T8 Arg2:T15	
R13	Before Arg1:T21 Arg2:T54	
A5	Experiencer T56 Patient
A6	Experiencer T36 Patient
A7	Experiencer T39 Patient
A8	Experiencer T58 Patient
A9	Experiencer T43 Patient
A10	Experiencer T47 Patient
A11	Experiencer T48 Patient
